Key facts
- Simparo Surgical’s last known valuation is $19.0M (Jan 2026).
- It has raised $3.4M; the latest was Later Stage VC ($1.0M) in Jan 2026.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Simparo Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for Simparo Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Simparo Surgical
Developer of a surgical fixation system designed to support efficient and reliable thumb CMC suspensionplasty reconstruction with controlled tensioning. The company offers a patented suture clutch with adjustable tension control, titanium anchor fixation, and straightforward instrumentation, enabling hand surgeons to perform thumb CMC suspensionplasty with consistent tensioning, secure fixation, and simplified suture management while minimizing surgical steps and operative complexity.
- Sector
- Healthcare
- HQ
- Mobile, AL, United States
- Founded
- 2013
- Employees
- 8
- Website
- simparosurgical.com/
- Ownership
- Privately Held (backing)
Simparo Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Simparo Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Simparo Surgical in its N-PORT filings yet. We sweep new filings monthly.